Literature DB >> 10479727

Restriction fragment analysis as a source of error in detection of heteroplasmic mtDNA mutations.

S Finnilä1, I E Hassinen, K Majamaa.   

Abstract

The transition from A to G at nt 5656 (5656A-->G) in mitochondrial DNA has been suggested to be a pathogenic mutation and, furthermore, a heteroplasmic one. We found that the mutation was present in 14 out of 83 healthy controls from northern Finland and that 5656A-->G was exclusively associated with mtDNA haplogroup U. Interestingly, 5656A-->G appeared to be heteroplasmic in NheI digestion of PCR fragments that were amplified by using a mismatched oligonucleotide primer creating a digestion site in the presence of the mutant variant. However, we did not detect the wild type genome in clones from such a sample and subsequent experiments revealed that the apparent heteroplasmy was due to inhibition of NheI by NaCl. Our results suggest that 5656A-->G is a polymorphism and it may be highly characteristic for Finns. Furthermore, new heteroplasmic mutations identified by restriction fragment analysis should be adequately controlled for any false positive results that may be due to incomplete digestion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479727     DOI: 10.1016/s1383-5726(99)00007-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis.

Authors:  S Finnilä; I E Hassinen; L Ala-Kokko; K Majamaa
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Sequence variation in the tRNA genes of human mitochondrial DNA.

Authors:  Tiina Vilmi; Jukka S Moilanen; Saara Finnilä; Kari Majamaa
Journal:  J Mol Evol       Date:  2005-05       Impact factor: 2.395

Review 3.  Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.

Authors:  Carlos T Moraes; David P Atencio; Jose Oca-Cossio; Francisca Diaz
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.